Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (141-150 of 266) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2018
Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall SurvivalEmmanuel S Antonarakis, Eric J Small, Daniel P Petrylak, et al.
Cancer Research|October 12, 2007
Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate cancer therapyEvan T Keller, David R Rowley, Scott A Tomlins, et al.
The Journal of Urology|March 3, 2020
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the BladderGuarionex J DeCastro, Wilson Sui, Jamie S Pak, et al.
The Prostate|June 22, 2016
Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial Ibrahim Kulac, Berrak Gumuskaya, Charles G Drake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibodyEvan J Lipson, William H Sharfman, Charles G Drake, et al.
Cancer Research|May 14, 2009
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer modelSatoshi Wada, Kiyoshi Yoshimura, Edward L Hipkiss, et al.
Journal of Translational Medicine|April 6, 2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerSatoshi Wada, Christopher M Jackson, Kiyoshi Yoshimura, et al.
Urologic Oncology|June 7, 2021
Telemedicine in management of genitourinary malignancies: Patient and physician perspectivesEzra J Margolin, Luis A Pina Martina, Caleb H Miles, et al.
Nature Immunology|February 7, 2012
The composition and signaling of the IL-35 receptor are unconventionalLauren W Collison, Greg M Delgoffe, Clifford S Guy, et al.
Cancer Research|August 21, 2020
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic CancerTamas A Gonda, Jarwei Fang, Martha Salas, et al.
Pageof 27

Showing results (141-150 of 266) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2018
Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall SurvivalEmmanuel S Antonarakis, Eric J Small, Daniel P Petrylak, et al.
Cancer Research|October 12, 2007
Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate cancer therapyEvan T Keller, David R Rowley, Scott A Tomlins, et al.
The Journal of Urology|March 3, 2020
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the BladderGuarionex J DeCastro, Wilson Sui, Jamie S Pak, et al.
The Prostate|June 22, 2016
Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial Ibrahim Kulac, Berrak Gumuskaya, Charles G Drake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibodyEvan J Lipson, William H Sharfman, Charles G Drake, et al.
Cancer Research|May 14, 2009
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer modelSatoshi Wada, Kiyoshi Yoshimura, Edward L Hipkiss, et al.
Journal of Translational Medicine|April 6, 2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerSatoshi Wada, Christopher M Jackson, Kiyoshi Yoshimura, et al.
Urologic Oncology|June 7, 2021
Telemedicine in management of genitourinary malignancies: Patient and physician perspectivesEzra J Margolin, Luis A Pina Martina, Caleb H Miles, et al.
Nature Immunology|February 7, 2012
The composition and signaling of the IL-35 receptor are unconventionalLauren W Collison, Greg M Delgoffe, Clifford S Guy, et al.
Cancer Research|August 21, 2020
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic CancerTamas A Gonda, Jarwei Fang, Martha Salas, et al.
Pageof 27